Skip to main content
. Author manuscript; available in PMC: 2023 Oct 12.
Published in final edited form as: Cell Rep. 2018 Nov 13;25(7):1841–1855.e5. doi: 10.1016/j.celrep.2018.10.056

Figure 6. ESCRT Knockdown Allows TGF-β to Drive EMT at Low Doses.

Figure 6

(A) NMuMG cells were transfected with non-targeting (NT) control siRNAs or siRNAs targeting Vps28 and treated or not with 0.5 ng/mL TGF-β for the times indicated. Cells were fixed and stained for TJP1, CDH1, and DAPI to mark nuclei and imaged by confocal microscopy. Scale bar, 50 μm.

(B) As in (A) except that cells were stained for actin using phalloidin. Scale bar, 30 μm.